Relationship between plasma total antioxidant capacity and thoracic aortic intima-media thickness

Recep Demirbag1, Remzi Yilmaz, A Sami Kunt

  • 1Department of Cardiology, Faculty of Medicine, Harran University, Sanliurfa, Turkey. rdemirbag@yahoo.com

Insights

Total antioxidant capacity (TAC) is linked to a lower risk of thoracic aortic atherosclerosis. Lower TAC levels correlate with increased thoracic aortic intima-media thickness (TAIMT) and atherosclerosis severity.

Area of Science:

  • Cardiovascular Medicine
  • Biochemistry
  • Medical Imaging

Background:

  • Antioxidants play a crucial role in preventing coronary artery disease (CAD).
  • Low total antioxidant capacity (TAC) is a known risk factor for ischemic heart disease.
  • Limited data exist on the relationship between TAC and thoracic aortic atherosclerosis severity.

Purpose of the Study:

  • To investigate the association between total antioxidant capacity (TAC) and atherosclerotic thoracic aortic intima-media thickness (TAIMT).
  • To determine if TAC is an independent predictor of thoracic aortic atherosclerosis.

Main Methods:

  • Utilized multiplane transesophageal echocardiography (TEE) to assess TAIMT and the grade of thoracic aortic atherosclerosis.
  • Measured TAC in 29 patients without a history of cardiovascular disease, excluding those with obesity, hypertension, diabetes, or CAD.
  • Employed a recently developed method for TAC measurement.

Main Results:

  • A significant negative correlation was observed between TAC levels and both TAIMT (r = -0.799) and the grade of thoracic aortic atherosclerosis (r = -0.827).
  • Multiple linear regression confirmed TAC as an independent predictor of TAIMT (beta = -0.734).
  • TAC levels progressively decreased with increasing grades of thoracic aortic atherosclerosis (Grade I: 2.23 ± 0.31; Grade II: 1.58 ± 0.31; Grade III: 1.04 ± 0.27 mmol Trolox equiv/l; ANOVA P < 0.001).

Conclusions:

  • Total antioxidant capacity (TAC) is an independent variable associated with thoracic aortic intima-media thickness (TAIMT).
  • TAC may serve as an independent predictor for atherosclerotic lesions in major arteries.
  • Findings suggest TAC's potential role in assessing the risk and severity of aortic atherosclerosis.

Related Concept Videos

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Thoracic Aorta01:15

Thoracic Aorta

The thoracic section of the aorta begins at the T5 vertebra and extends to the T12 level at the diaphragm, initially progressing through the mediastinum to the left of the spinal column. Throughout its course in the thoracic segment, the thoracic aorta emits various offshoots known collectively as visceral and parietal branches. The branches that predominantly supply blood to visceral organs are termed visceral branches and include bronchial, pericardial, esophageal, and mediastinal arteries,...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Aneurysm II: Clinical Manifestations and Diagnostic Studies01:21

Aneurysm II: Clinical Manifestations and Diagnostic Studies

Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...